Goldenrod

Materia Medica

Goldenrod

Solidago virgaurea

European goldenrod is a yellow-flowered perennial of the daisy family whose flowering tops are a traditional European remedy for the urinary tract, taken as a tea to increase urine flow and ease bladder irritation. It is rich in flavonoids, the phenolic glycoside leiocarposide and triterpene saponins.

What Is Goldenrod?

European goldenrod is a yellow-flowered perennial in the daisy family, used in European herbal medicine as a remedy for the urinary tract. Its flowering tops are taken as a tea to increase the flow of urine and to calm an irritated bladder, and it is a traditional companion to treatment for cystitis and kidney gravel 2,3Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

The plant grows wild across Europe. Its urinary use goes back at least to the medieval physician Arnold of Villanova, and German folk medicine knew it as “heathen woundwort” for its use on wounds 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

The flowering herb carries flavonoids such as rutin and hyperoside, the phenolic glycoside leiocarposide, and triterpene saponins 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →. Research has looked at its anti-inflammatory, diuretic and anti-biofilm activity, almost entirely in animals and in the laboratory 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

Goldenrod is often blamed for hay fever because it is confused with ragweed. The wind-borne pollen that causes those allergies comes from ragweed, not goldenrod 29Reference 29North Carolina State University ExtensioSolidago (goldenrod) — Extension Gardener Plant Toolbox — genus profileView study →.

How Is Goldenrod Used?

Goldenrod is taken as a tea, tincture, liquid extract or dry extract, often in combination products alongside other urinary herbs 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →. It is drunk with plenty of fluid, since its purpose is to increase the flow of urine 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

  • Tea — 3–5 g of dried herb as an infusion, two to four times a day 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.
  • Tincture or liquid extract — 0.5–2 mL three times a day 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.
  • Dry extract — 350–450 mg three times a day 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

It is traditionally taken for two to four weeks at a time 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

Traditional Uses

Western Herbal Medicine

Western herbalists use goldenrod as a urinary antiseptic, a diuretic that increases water loss, an anti-inflammatory and a mild astringent.

It is given for cystitis, urinary tract infections, kidney gravel, urethral irritation, mild fluid retention and inflammation of the urinary tract. It has also been used for wounds, sore throats and catarrh.

The European Medicines Agency recognises its traditional use to increase the amount of urine, as a support in minor urinary complaints 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

German & Central European Folk Medicine

German folk medicine called goldenrod Heydnisch Wundkraut, “heathen woundwort”, for its use in healing wounds 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →. The 16th-century botanist Tabernaemontanus wrote that it cleanses the kidneys and urinary tract. It was used for urinary retention, kidney stones and haemorrhoids 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

In Poland the infusion of the dried flowering herb is a traditional diuretic and a support for minor urinary complaints. It has also been used as a disinfectant, to speed wound healing, and in skin care 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

Across Europe it is a common ingredient in teas meant to help pass kidney stones, and it is used for urinary tract infections, an overactive bladder and prostate complaints. Infusions are also used as a mouth rinse for inflammation of the mouth and throat 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

Russian Folk Medicine

Russian folk medicine uses goldenrod for a range of complaints, from gallstones and indigestion to rheumatism and gout. Fresh leaves are applied to abscesses and boils 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

Botany

European goldenrod is a perennial herb in the daisy family (Asteraceae). It grows from an oblique, woody rhizome, and its round, upright stem reaches up to 1 m, branching and hairy towards the top 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

The lower leaves are oval to elliptic, with a pointed tip and a winged stalk. The upper leaves are narrower, lance-shaped and short-stalked, with toothed or smooth edges 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

The small yellow flower heads carry both ray and disc florets. They are gathered into simple spikes or branched clusters at the top of the stem 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →. The fruit is a ribbed, cylindrical achene topped with a tuft of bristles 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

Its flowers draw bees, flies and butterflies 29Reference 29North Carolina State University ExtensioSolidago (goldenrod) — Extension Gardener Plant Toolbox — genus profileView study →. The medicinal part is the flowering aerial part, gathered as the plant comes into bloom 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

Solidago virgaurea is extremely variable. Botanists have split it into many subspecies and closely related forms, and it belongs to a group of goldenrods that stretches from Europe to East Asia 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →. In Germany, the North American S. canadensis and S. gigantea are also accepted as goldenrod herb, though their chemistry differs 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

Distribution

European goldenrod is native to Europe, including Britain and Ireland, where it takes many forms suited to different habitats 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →. Its close relatives continue east through Siberia and into the Russian Far East 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

The goldenrods that invade habitats in Europe are two North American species, S. canadensis and S. gigantea, not S. virgaurea 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

Growing Conditions

Cultivation snapshot for Goldenrod

LifeperennialZoneUSDA 4–8
  • Grows as a hardy perennial, dying back in winter and returning from the rootstock each spring.
  • Happy in full sun to part shade; tolerant of a wide range of soils, from acid to alkaline, including heavy clay.
  • Prefers moisture-retentive ground but copes with both dry and moist conditions once established.
  • Forms an upright clump usually around 60 cm tall; flowers from mid-summer into autumn, drawing bees and hoverflies.

Grow it yourself

Farm Wiki is our cultivation-focused sister site, also run by Justin Cooke.

How to growComing soon
Find seedsComing soon

Indications

  • Minor urinary complaints, to increase urine flow [herb tea; European traditional use]
  • Cystitis and bladder irritation [aerial parts; Western herbal use]
  • Urinary tract infections [aerial parts; Western herbal use] Caution: In the laboratory, extracts disrupt the adhesion and biofilms of Candida and urinary bacteria rather than reliably killing them. In one study an extract weakened the antibiotics amikacin and ciprofloxacin 11,16.
  • Kidney gravel and stones [herb tea; European folk use]
  • Mild fluid retention [herb tea; Western herbal use]
  • Overactive bladder [aerial parts; European use]
  • Prostate complaints [aerial parts; European folk use]
  • Wounds [aerial parts; German and Polish folk use]
  • Sore throat and mouth inflammation [infusion as mouth rinse; folk use]
  • Rheumatism and gout [aerial parts; Russian folk use]

Pharmacology & Research

Several dozen studies have been published on European goldenrod, almost all in the laboratory or in animals 1,2Reference 1ESCOP · 2008ReviewSolidaginis virgaureae herba (European Goldenrod) — pharmacopoeial monograph (review)Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →. Most human trials that include it test a multi-herb product.

The best-characterised activities match the traditional urinary use: anti-inflammatory activity, increased urine output, and disruption of the adhesion and biofilms of Candida and urinary bacteria 2,5,11Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →Reference 5Abdel Motaal A et al. · 2016AnimalIn vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats — carrageenan paw-edema, in vivo animal modelView study →Reference 11Chevalier M et al. · 2012In vitroInhibition of Candida albicans yeast-hyphal transition and biofilm formation by Solidago virgaurea water extracts — in vitroView study →.

The one human trial of goldenrod on its own is an oral-hygiene trial of a goldenrod toothpaste 14Reference 14Prêcheur I et al. · 2020RCTSolidago virgaurea LView study →.

What the Evidence Supports
  • Best-supported: anti-inflammatory activity from caffeoylquinic acids and leiocarposide in animal models 5,6Reference 5Abdel Motaal A et al. · 2016AnimalIn vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats — carrageenan paw-edema, in vivo animal modelView study →Reference 6Metzner J et al. · 1984AnimalAntiphlogistic and analgesic effects of leiocarposide, a phenolic bisglucoside of Solidago virgaurea L. — in vivo animal modelView study →; diuresis from flavonoid fractions in rats 17Reference 17Chodera A et al. · 1991AnimalEffect of flavonoid fractions of Solidago virgaurea L. on diuresis and levels of electrolytes — in vivo rat studyView study →; anti-adhesion/anti-biofilm effects against Candida albicans and uropathogenic bacteria in vitro 11,12,16Reference 11Chevalier M et al. · 2012In vitroInhibition of Candida albicans yeast-hyphal transition and biofilm formation by Solidago virgaurea water extracts — in vitroView study →Reference 12Chevalier M et al. · 2019In vitroInhibition of adhesion-specific genes by Solidago virgaurea extract causes loss of Candida albicans biofilm integrity — in vitro (gene expression)View study →Reference 16Wojnicz D et al. · 2021In vitroIs it Worth Combining Solidago virgaurea Extract and Antibiotics against Uropathogenic Escherichia coli rods? An In Vitro Model Study — in vitro biofilm and antibiotic-synergy studyView study →.
  • Emerging, worth watching: inhibition of bladder smooth-muscle contraction via muscarinic receptors in rat and human tissue 19Reference 19Borchert VE et al. · 2004In vitroExtracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction — in vitro tissue-bath and muscarinic receptor studyView study →; antidiabetic/hypolipidemic signals in rodents 20,21Reference 20Zehra SA et al. · 2023In vitroIn Vitro and In Vivo Evaluation of the Antidiabetic Activity of Solidago virgaurea Extracts — in vitro enzyme/cell and in vivo animal studyView study →Reference 21Sanad FA et al. · 2022AnimalAntidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type 1 — in vivo rat studyView study →.
  • Mechanistically thin: antioxidant and cardioprotective claims rest on enzyme-model and single-animal studies, and one careful assay found goldenrod had no effect on myeloperoxidase 8,9,24Reference 8Meyer B et al. · 1995In vitroAntioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea — in vitro enzyme-model studyView study →Reference 9von Kruedener S et al. · 1996In vitroEffects of extracts from Populus tremula L., Solidago virgaurea L. and Fraxinus excelsior L. on various myeloperoxidase systems — in vitro (goldenrod null result)View study →Reference 24El-Tantawy WH · 2014AnimalBiochemical effects of Solidago virgaurea extract on experimental cardiotoxicity — in vivo rat studyView study →.
  • The caveat: virtually no single-herb human trials for the urinary indications; effects vary by subspecies, plant part and extract type, and there is no standardized clinical dose 1,2Reference 1ESCOP · 2008ReviewSolidaginis virgaureae herba (European Goldenrod) — pharmacopoeial monograph (review)Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

The preparation and the subspecies both change the result. Infusions, hydroalcoholic tinctures, saponin fractions and essential oils differ in their chemistry and activity, and many studies do not state which subspecies they used 2,23Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →Reference 23Nkuimi Wandjou JG et al. · 2020In vitroChemical Composition and Antiproliferative Effect of Essential Oils of Four Solidago Species — in vitro cell-line studyView study →.

Evidence by IndicationStrength of support
70%
AntioxidantPromising
58%
1. Anti-Inflammatory

This is goldenrod’s best-mapped activity. A phenolic-rich fraction of the aerial parts, and four caffeoylquinic acids isolated from it, including 3,5-di-O-caffeoylquinic acid, reduced carrageenan-induced paw oedema in rats and lowered TNF-α and IL-1β, at 25–50 mg/kg 5Reference 5Abdel Motaal A et al. · 2016AnimalIn vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats — carrageenan paw-edema, in vivo animal modelView study →. The most active was 3,4,5-tri-O-caffeoylquinic acid, which at 50 mg/kg matched 88% of the effect of indometacin at 10 mg/kg 5Reference 5Abdel Motaal A et al. · 2016AnimalIn vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats — carrageenan paw-edema, in vivo animal modelView study →.

The phenolic glycoside leiocarposide showed anti-inflammatory and pain-relieving activity in classic animal models 6Reference 6Metzner J et al. · 1984AnimalAntiphlogistic and analgesic effects of leiocarposide, a phenolic bisglucoside of Solidago virgaurea L. — in vivo animal modelView study →.

⚠ An aqueous goldenrod infusion did not significantly change the inflammatory activity of human neutrophils in vitro. Most of its compounds did not cross a model of the gut wall, but the smaller molecules that gut bacteria made from them did 10Reference 10Popowski D et al. · 2021In vitroGut microbiota metabolism and the permeability of natural products contained in infusions from herb of European goldenrod Solidago virgaurea L. — in vitro (Caco-2, human/piglet microbiota)View study →.

Much of the older evidence comes from the fixed combination STW 1 / Phytodolor (aspen, goldenrod and ash). In animals the combination had anti-inflammatory, pain-relieving and fever-reducing effects similar to salicyl alcohol and indometacin, and each extract contributed 7Reference 7Okpanyi SN et al. · 1989AnimalAnti-inflammatory, analgesic and antipyretic effect of various plant extracts and their combinations in an animal model (STW 1) — in vivo animal modelView study →.

Gap: No single-herb human trial; the strongest clinical data are for a three-herb product, and one enzyme study found goldenrod alone did not inhibit myeloperoxidase 9Reference 9von Kruedener S et al. · 1996In vitroEffects of extracts from Populus tremula L., Solidago virgaurea L. and Fraxinus excelsior L. on various myeloperoxidase systems — in vitro (goldenrod null result)View study →.

2. Antimicrobial / Anti-Biofilm

Water extracts of goldenrod did not inhibit the growth of Candida albicans or of common bacteria including E. coli, but they strongly inhibited Candida’s switch from yeast to hyphae and its biofilms 11Reference 11Chevalier M et al. · 2012In vitroInhibition of Candida albicans yeast-hyphal transition and biofilm formation by Solidago virgaurea water extracts — in vitroView study →. The extracts were chosen for their saponins 11Reference 11Chevalier M et al. · 2012In vitroInhibition of Candida albicans yeast-hyphal transition and biofilm formation by Solidago virgaurea water extracts — in vitroView study →. At the gene level, the extract turned down the adhesion and hyphal genes ALS3, HWP1 and ECE1, and it strengthened the effect of miconazole, nystatin and an antiseptic mouthwash 12Reference 12Chevalier M et al. · 2019In vitroInhibition of adhesion-specific genes by Solidago virgaurea extract causes loss of Candida albicans biofilm integrity — in vitro (gene expression)View study →.

Bioassay-guided work isolated six oleanane-type triterpenoid saponins, four of which inhibited the yeast-to-hypha switch 13Reference 13Laurençon L et al. · 2013In vitroTriterpenoid saponins from the aerial parts of Solidago virgaurea alpestris with inhibiting activity of Candida albicans yeast-hyphal conversion — in vitro, bioassay-guided isolationView study →.

Against uropathogenic E. coli, an extract reduced the survival of free-floating bacteria and 24-hour biofilm. ⚠ Combined with amikacin or ciprofloxacin, it weakened the antibiotics and shortened their post-antibiotic effect 16Reference 16Wojnicz D et al. · 2021In vitroIs it Worth Combining Solidago virgaurea Extract and Antibiotics against Uropathogenic Escherichia coli rods? An In Vitro Model Study — in vitro biofilm and antibiotic-synergy studyView study →. An extract also inhibited biofilm formation and ESBL enzyme activity in Pseudomonas aeruginosa 15Reference 15Abdulkareem AH et al. · 2023In vitroImpact of Solidago virgaurea Extract on Biofilm Formation for ESBL-Pseudomonas aeruginosa: An In Vitro Model Study — in vitroView study →.

In a randomised, double-blind trial in 66 healthy adults (33 per group), a fluoride toothpaste containing goldenrod extract was used twice daily for four weeks. Total bacterial load, Streptococcus mutans and C. albicans in dental plaque fell in the goldenrod group, and plaque and gum scores improved in both groups 14Reference 14Prêcheur I et al. · 2020RCTSolidago virgaurea LView study →.

Gap: All bacterial data are in vitro; extracts act on adhesion more than on survival, and goldenrod does not replace antibiotics in a urinary infection.

3. Aquaretic / Diuretic

The diuretic action underpins goldenrod’s traditional urinary use. The German Commission E calls it “irrigation therapy”, and the EMA/HMPC lists it to increase the amount of urine as a support in minor urinary complaints 3,4Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →Reference 4Blumenthal · 1998ReviewSolidaginis virgaureae herba (European goldenrod herb) — German Commission E approved monograph (irrigation therapy, lower urinary tract) — review.

Flavonoid fractions from the flowers of four goldenrods (S. virgaurea, S. gigantea and two forms of S. canadensis) were given by mouth to rats. Overnight urine output rose by 57–88% across the fractions, while overnight sodium and potassium excretion fell 17Reference 17Chodera A et al. · 1991AnimalEffect of flavonoid fractions of Solidago virgaurea L. on diuresis and levels of electrolytes — in vivo rat studyView study →. An isolated Solidago glycoside also had a diuretic effect 18Reference 18Chodera A et al. · 1985AnimalDiuretic effect of the glycoside from a plant of the Solidago L. genus — in vivo animal studyView study →.

Gap: The quantitative diuresis data are decades old and rodent-only; no modern controlled human study has measured goldenrod’s diuretic effect or defined an effective dose.

4. Antioxidant

Hydroalcoholic goldenrod extracts inhibit oxidative model reactions, including xanthine oxidase, lipoxygenase and light-driven riboflavin and rose bengal reactions, in vitro 8Reference 8Meyer B et al. · 1995In vitroAntioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea — in vitro enzyme-model studyView study →.

An LC-MS study of goldenrod herb identified quercetin, kaempferol and isorhamnetin glycosides, with caffeoylquinic and caffeoyl-shikimic acids, as its antioxidant components. The samples in that study were Canadian goldenrod (S. canadensis) 25Reference 25Apáti P et al. · 2004In vitroHPLC investigation of antioxidant components in Solidago herba — in vitro analytical/LC-MS studyView study →. In European goldenrod the main flavonoids are also derived from quercetin and kaempferol 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

These activities are measured entirely in cell-free systems. No study has shown that oral goldenrod raises antioxidant status in a person.

5. Bladder Antispasmodic

Goldenrod extract, at 0.01–0.1%, reduced carbachol-induced contraction of both rat and human bladder strips in a concentration-dependent way 19Reference 19Borchert VE et al. · 2004In vitroExtracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction — in vitro tissue-bath and muscarinic receptor studyView study →. Studies on cloned M2 and M3 muscarinic receptors showed a direct but non-competitive effect, and at higher concentrations part of the effect did not involve the receptors at all 19Reference 19Borchert VE et al. · 2004In vitroExtracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction — in vitro tissue-bath and muscarinic receptor studyView study →.

Muscarinic receptors are the target of drugs for an overactive bladder. The finding comes from one research group working in isolated tissue and cells, and the authors noted that a benefit in patients remains to be shown 19Reference 19Borchert VE et al. · 2004In vitroExtracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction — in vitro tissue-bath and muscarinic receptor studyView study →.

6. Antidiabetic / Hypolipidemic

Goldenrod extracts inhibited the enzymes α-glucosidase and PTP1B, reduced advanced glycation end-products, and increased GLUT4-mediated glucose uptake in rat muscle cells. In diabetic mice, 100 mg/kg of a methanolic extract injected daily for 24 days lowered blood glucose after meals, comparably to glibenclamide 20Reference 20Zehra SA et al. · 2023In vitroIn Vitro and In Vivo Evaluation of the Antidiabetic Activity of Solidago virgaurea Extracts — in vitro enzyme/cell and in vivo animal studyView study →.

In alloxan-diabetic rats, 250 mg/kg by mouth for 15 days lowered blood glucose, serum amylase, TNF-α and pancreatic lipid peroxidation, and raised insulin, liver glycogen and antioxidant enzymes 21Reference 21Sanad FA et al. · 2022AnimalAntidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type 1 — in vivo rat studyView study →.

Gap: two rodent and cell studies with no human data, in a direction unrelated to goldenrod’s urinary use.

7. Anticancer / Antiproliferative

A water-soluble fraction of about 40 kDa, found mostly in the leaves, was toxic to human prostate, breast, melanoma and lung cancer cell lines. Given by injection every three days at 5 mg/kg, it slowed the growth of rat prostate tumours implanted in SCID mice 22Reference 22Gross SC et al. · 2002AnimalAntineoplastic activity of Solidago virgaurea on prostatic tumor cells in an SCID mouse model — in vivo animal modelView study →.

Goldenrod essential oils, rich in germacrene D, α-pinene and bornyl acetate, slowed the growth of breast, melanoma and colon cancer cell lines 23Reference 23Nkuimi Wandjou JG et al. · 2020In vitroChemical Composition and Antiproliferative Effect of Essential Oils of Four Solidago Species — in vitro cell-line studyView study →.

Gap: the essential-oil data use a volatile preparation goldenrod is not taken as, and the tumour work is a single mouse study using injection.

8. Cardioprotective

In a single rat study, 5 weeks of pre-treatment with 250 mg/kg of goldenrod extract prevented the heart damage caused by isoproterenol. It limited the rise in cardiac enzymes (LDH, CPK), blood lipids, malondialdehyde and nitric oxide, and preserved glutathione and superoxide dismutase 24Reference 24El-Tantawy WH · 2014AnimalBiochemical effects of Solidago virgaurea extract on experimental cardiotoxicity — in vivo rat studyView study →. The finding has not been repeated.

Mechanisms

Goldenrod’s urinary activity has been linked to three groups of compounds. Its flavonoids increased urine output in rats, its caffeoylquinic acids and leiocarposide reduced inflammation in animal models, and its triterpene saponins disrupted the adhesion and biofilms of Candida 5,6,13,17Reference 5Abdel Motaal A et al. · 2016AnimalIn vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats — carrageenan paw-edema, in vivo animal modelView study →Reference 6Metzner J et al. · 1984AnimalAntiphlogistic and analgesic effects of leiocarposide, a phenolic bisglucoside of Solidago virgaurea L. — in vivo animal modelView study →Reference 13Laurençon L et al. · 2013In vitroTriterpenoid saponins from the aerial parts of Solidago virgaurea alpestris with inhibiting activity of Candida albicans yeast-hyphal conversion — in vitro, bioassay-guided isolationView study →Reference 17Chodera A et al. · 1991AnimalEffect of flavonoid fractions of Solidago virgaurea L. on diuresis and levels of electrolytes — in vivo rat studyView study →.

Whole extracts also act on muscarinic receptors in bladder muscle 19Reference 19Borchert VE et al. · 2004In vitroExtracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction — in vitro tissue-bath and muscarinic receptor studyView study →.

MechanismDrivesKey compounds
TNF-α ↓, IL-1β ↓; radical scavenging
anti-inflammatoryantioxidant
3,5-dicaffeoylquinic acid, caffeic acid, chlorogenic acid
Antiphlogistic / analgesic
anti-inflammatoryanalgesic
leiocarposide
Increased urine output; antioxidant
aquaretic/diureticantioxidant
rutin, quercitrin, isoquercitrin, hyperoside
Disruption of Candida hyphae/biofilm; cell-line cytotoxicity
antimicrobial/anti-biofilmanticancer
virgaureasaponins, solidagosaponins
M2/M3 muscarinic receptor effects
bladder antispasmodic
whole aqueous/hydroalcoholic extract

Clinical Trials

No registered trial has tested goldenrod by mouth as a single herb. The human trials identified here are a single-herb toothpaste trial 14Reference 14Prêcheur I et al. · 2020RCTSolidago virgaurea LView study → and two trials of combination products.

In people with indwelling urinary catheters, a tablet of goldenrod, orthosiphon, birch and cranberry for 30 days lowered the rate of positive urine cultures (10 of 43 against 16 of 30 untreated) 26Reference 26Cai T et al. · 2014RCTSolidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study — randomised controlled pilot trial (combination product)View study →. In a 2026 open-label trial in 60 people with ureteral stents, a five-herb capsule containing goldenrod was compared with tamsulosin. Tamsulosin did better on the urinary-symptom score, and the other measures did not differ 27Reference 27Gallo G et al. · 2026RCTA randomized controlled trial comparing alpha-blocker (tamsulosin) and a phyto-complex (Solidago virga-aurea, Phyllantus niruri, Epilobium angustifolium, Peumus boldus and Ononis spinosa) in the treatment of ureteral stent-related symptoms — randomised controlled trial (combination product)View study →.

CompletedPlannedTerminatedPreclinical
3identified (1 single-herb toothpaste, 2 combination products) 14,26,27Reference 14Prêcheur I et al. · 2020RCTSolidago virgaurea LView study →Reference 26Cai T et al. · 2014RCTSolidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study — randomised controlled pilot trial (combination product)View study →Reference 27Gallo G et al. · 2026RCTA randomized controlled trial comparing alpha-blocker (tamsulosin) and a phyto-complex (Solidago virga-aurea, Phyllantus niruri, Epilobium angustifolium, Peumus boldus and Ononis spinosa) in the treatment of ureteral stent-related symptoms — randomised controlled trial (combination product)View study →00~40–50

Last checked: July 2026.

Phytochemistry

The European Pharmacopoeia sets goldenrod’s flavonoid content at 0.5–1.5%, expressed as hyperoside, and uses the flavonoids as its quality markers 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →. The main ones are glycosides of quercetin and kaempferol, among them rutin, quercitrin, isoquercitrin and hyperoside, with an isorhamnetin glycoside (narcissin) and the free aglycones quercetin, kaempferol and isorhamnetin 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

The phenolic glycoside leiocarposide makes up about 0.4–1.6% of the herb, peaking in the flower buds 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →. The herb also carries many oleanane-type triterpene saponins, the virgaureasaponins and solidagosaponins 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

Phenolic acids include caffeic acid, chlorogenic acid and several caffeoylquinic acids, among them 3,5-dicaffeoylquinic acid 2,5Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →Reference 5Abdel Motaal A et al. · 2016AnimalIn vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats — carrageenan paw-edema, in vivo animal modelView study →. Tannins are also present 1Reference 1ESCOP · 2008ReviewSolidaginis virgaureae herba (European Goldenrod) — pharmacopoeial monograph (review).

The essential oil varies with origin. In three Polish samples it was led by α-pinene (27–34%), with germacrene D at 8–17%, while Lithuanian oils were dominated by caryophyllene oxide and other oxygenated compounds 2Reference 2Fursenco C et al. · 2020Systematic reviewSolidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic reviewView study →.

Constituent Summary

Reported from the flowering aerial parts.

Grouped by class · 12 compounds
Flavonoid7 compoundsno data
FlavonoidRutinNo data
FlavonoidQuercitrinNo data
FlavonoidIsoquercitrinNo data
FlavonoidHyperosideNo data
FlavonoidQuercetinNo data
FlavonoidKaempferolNo data
FlavonoidIsorhamnetinNo data
Phenolic Glycoside1 compound1 with data
Phenolic GlycosideLeiocarposide~0.4–1.6% (dry)
Saponin1 compoundno data
SaponinVirgaureasaponinsNo data
Phenolic Acid2 compoundsno data
Phenolic AcidCaffeic acidNo data
Phenolic AcidChlorogenic acidNo data
Tannin1 compoundno data
TanninTanninsNo data

Dosage

Human doses follow the European traditional-use monograph. Goldenrod is taken with plenty of fluid 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

Research Doses

IndicationPreparationDoseEst. dried-herb equivalentSource
Anti-inflammatory (rat paw-edema)Caffeoylquinic-acid-rich fraction25–50 mg/kg (rat)Not human-translatable5Reference 5Abdel Motaal A et al. · 2016AnimalIn vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats — carrageenan paw-edema, in vivo animal modelView study →
Diuresis (rat)Flavonoid fractions of four Solidago species, oralFraction dose raising urine output 57–88%Not human-translatable17Reference 17Chodera A et al. · 1991AnimalEffect of flavonoid fractions of Solidago virgaurea L. on diuresis and levels of electrolytes — in vivo rat studyView study →
Antidiabetic (alloxan rat)Whole extract, 15 days250 mg/kg (rat)Not human-translatable21Reference 21Sanad FA et al. · 2022AnimalAntidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type 1 — in vivo rat studyView study →

These are animal doses of fractions or extracts and do not convert to a human dose.

Traditional Dosage

SystemPreparationDose
EMA/HMPC (traditional use)Dried herb as infusion3–5 g, 2–4× daily
EMA/HMPC (traditional use)Liquid extract or tincture0.5–2 mL, 3× daily
EMA/HMPC (traditional use)Dry extract350–450 mg, 3× daily
German Commission EDried herb (irrigation therapy)6–12 g/day
Western herbal (liquid extract)1:2 liquid extract20–40 mL/week

The EMA doses are for adults and adolescents, taken for two to four weeks 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

Safety & Pregnancy

Goldenrod is generally well tolerated. The main cautions are daisy-family allergy and conditions where fluid intake has to be limited.

Safety at a Glance
Low / no toxicityDaisy-family allergy
  • Generally well tolerated. Allergic reactions and stomach upsets can occur, but how often is not known.
  • Severe heart or kidney disease. Not for use where a reduced fluid intake is advised, as in severe heart or kidney disease.
  • Daisy-family allergy. Do not use if allergic to goldenrod or other Asteraceae plants. Contact dermatitis has been reported.
  • Prescription diuretics. Use alongside synthetic diuretics is not recommended.
  • When to see a doctor. Seek advice if symptoms persist, or with fever, painful urination, spasms or blood in the urine.
Full Safety & Interactions Detail

Side effects. Hypersensitivity reactions and stomach and bowel upsets may occur, and their frequency is not known 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →. Contact dermatitis from goldenrod has been reviewed among the skin reactions to European herbal medicines 28Reference 28Minciullo PL et al. · 2017ReviewContact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 4: Solidago virgaurea-Vitis vinifera — review of adverse reactionsView study →.

Who should not take it. The European monograph lists allergy to goldenrod or other daisy-family (Asteraceae) plants as a contraindication. It also rules out conditions where a reduced fluid intake is recommended, such as severe heart or kidney disease 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

Diuretics. Taking goldenrod alongside synthetic diuretics is not recommended 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →. No other drug interactions have been reported 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

Children. It is not recommended under 12 years of age, for lack of experience 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

When to see a doctor. Fever, painful urination, spasms or blood in the urine during use need a doctor’s assessment, as do symptoms that persist 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

Pregnancy & Lactation
Avoid in pregnancy Avoid while breastfeeding

Not recommended. The European monograph does not recommend goldenrod in pregnancy or while breastfeeding, because there are not enough data 3Reference 3EMA/HMPC · 2008ReviewCommunity herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monographView study →.

References

  1. ESCOP (2008). Solidaginis virgaureae herba (European Goldenrod) — pharmacopoeial monograph (review). ESCOP Monographs, 2nd ed., Supplement. European Scientific Cooperative on Phytotherapy.
  2. Fursenco C, et al. (2020). Solidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities — systematic review. Biomolecules, 10(12). https://pubmed.ncbi.nlm.nih.gov/33266185/
  3. EMA/HMPC (2008). Community herbal monograph on Solidago virgaurea L., herba — traditional-use regulatory monograph. European Medicines Agency, Committee on Herbal Medicinal Products (EMEA/HMPC/285758/2007). https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-solidago-virgaurea-l-herba_en.pdf
  4. Blumenthal, M. (ed.) (1998). Solidaginis virgaureae herba (European goldenrod herb) — German Commission E approved monograph (irrigation therapy, lower urinary tract) — review. The Complete German Commission E Monographs, American Botanical Council.
  5. Abdel Motaal A, et al. (2016). In vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats — carrageenan paw-edema, in vivo animal model. Pharmaceutical Biology, 54(12):2864–2870. https://pubmed.ncbi.nlm.nih.gov/27249953/
  6. Metzner J, et al. (1984). Antiphlogistic and analgesic effects of leiocarposide, a phenolic bisglucoside of Solidago virgaurea L. — in vivo animal model. Die Pharmazie, 39(12):869–70. https://pubmed.ncbi.nlm.nih.gov/6531401/
  7. Okpanyi SN, et al. (1989). Anti-inflammatory, analgesic and antipyretic effect of various plant extracts and their combinations in an animal model (STW 1) — in vivo animal model. Arzneimittel-Forschung, 39(6):698–703. https://pubmed.ncbi.nlm.nih.gov/2476136/
  8. Meyer B, et al. (1995). Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea — in vitro enzyme-model study. Arzneimittel-Forschung, 45(2):174–6. https://pubmed.ncbi.nlm.nih.gov/7710443/
  9. von Kruedener S, et al. (1996). Effects of extracts from Populus tremula L., Solidago virgaurea L. and Fraxinus excelsior L. on various myeloperoxidase systems — in vitro (goldenrod null result). Arzneimittel-Forschung, 46(8):809–14. https://pubmed.ncbi.nlm.nih.gov/9125284/
  10. Popowski D, et al. (2021). Gut microbiota metabolism and the permeability of natural products contained in infusions from herb of European goldenrod Solidago virgaurea L. — in vitro (Caco-2, human/piglet microbiota). Journal of Ethnopharmacology, 273:113924. https://pubmed.ncbi.nlm.nih.gov/33607199/
  11. Chevalier M, et al. (2012). Inhibition of Candida albicans yeast-hyphal transition and biofilm formation by Solidago virgaurea water extracts — in vitro. Journal of Medical Microbiology, 61(Pt 7):1016–1022. https://pubmed.ncbi.nlm.nih.gov/22422572/
  12. Chevalier M, et al. (2019). Inhibition of adhesion-specific genes by Solidago virgaurea extract causes loss of Candida albicans biofilm integrity — in vitro (gene expression). Journal of Applied Microbiology, 127(1):68–77. https://pubmed.ncbi.nlm.nih.gov/31013388/
  13. Laurençon L, et al. (2013). Triterpenoid saponins from the aerial parts of Solidago virgaurea alpestris with inhibiting activity of Candida albicans yeast-hyphal conversion — in vitro, bioassay-guided isolation. Phytochemistry, 86:103–11. https://pubmed.ncbi.nlm.nih.gov/23137724/
  14. Prêcheur I, et al. (2020). Solidago virgaurea L. Plant Extract Targeted Against Candida albicans to Reduce Oral Microbial Biomass: a Double Blind Randomized Trial on Healthy Adults — randomised, double-blind controlled clinical trial (n=66, 4 weeks). Antibiotics (Basel), 9(4). https://pubmed.ncbi.nlm.nih.gov/32218125/
  15. Abdulkareem AH, et al. (2023). Impact of Solidago virgaurea Extract on Biofilm Formation for ESBL-Pseudomonas aeruginosa: An In Vitro Model Study — in vitro. Pharmaceuticals (Basel), 16(10). https://pubmed.ncbi.nlm.nih.gov/37895854/
  16. Wojnicz D, et al. (2021). Is it Worth Combining Solidago virgaurea Extract and Antibiotics against Uropathogenic Escherichia coli rods? An In Vitro Model Study — in vitro biofilm and antibiotic-synergy study. Pharmaceutics, 13(4). https://pubmed.ncbi.nlm.nih.gov/33920649/
  17. Chodera A, et al. (1991). Effect of flavonoid fractions of Solidago virgaurea L. on diuresis and levels of electrolytes — in vivo rat study. Acta Poloniae Pharmaceutica, 48(5-6):35–7. https://pubmed.ncbi.nlm.nih.gov/1669338/
  18. Chodera A, et al. (1985). Diuretic effect of the glycoside from a plant of the Solidago L. genus — in vivo animal study. Acta Poloniae Pharmaceutica, 42(2):199–204. https://pubmed.ncbi.nlm.nih.gov/4083055/
  19. Borchert VE, et al. (2004). Extracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction — in vitro tissue-bath and muscarinic receptor study. Naunyn-Schmiedeberg’s Archives of Pharmacology, 369(3):281–6. https://pubmed.ncbi.nlm.nih.gov/14963639/
  20. Zehra SA, et al. (2023). In Vitro and In Vivo Evaluation of the Antidiabetic Activity of Solidago virgaurea Extracts — in vitro enzyme/cell and in vivo animal study. Current Bioactive Compounds, 19(4). https://pubmed.ncbi.nlm.nih.gov/37900701/
  21. Sanad FA, et al. (2022). Antidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type 1 — in vivo rat study. Archives of Physiology and Biochemistry, 128(3):716–723. https://pubmed.ncbi.nlm.nih.gov/32026741/
  22. Gross SC, et al. (2002). Antineoplastic activity of Solidago virgaurea on prostatic tumor cells in an SCID mouse model — in vivo animal model. Nutrition and Cancer, 43(1):76–81. https://pubmed.ncbi.nlm.nih.gov/12467138/
  23. Nkuimi Wandjou JG, et al. (2020). Chemical Composition and Antiproliferative Effect of Essential Oils of Four Solidago Species — in vitro cell-line study. Chemistry & Biodiversity, 17(11):e2000685. https://pubmed.ncbi.nlm.nih.gov/32930493/
  24. El-Tantawy WH (2014). Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity — in vivo rat study. Journal of Physiology and Biochemistry, 70(1):33–42. https://pubmed.ncbi.nlm.nih.gov/23872883/
  25. Apáti P, et al. (2004). HPLC investigation of antioxidant components in Solidago herba — in vitro analytical/LC-MS study. Acta Pharmaceutica Hungarica, 74(4):223–31. https://pubmed.ncbi.nlm.nih.gov/16316050/
  26. Cai T, et al. (2014). Solidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study — randomised controlled pilot trial (combination product). World Journal of Urology, 32(4):1007–14. https://pubmed.ncbi.nlm.nih.gov/24092275/
  27. Gallo G, et al. (2026). A randomized controlled trial comparing alpha-blocker (tamsulosin) and a phyto-complex (Solidago virga-aurea, Phyllantus niruri, Epilobium angustifolium, Peumus boldus and Ononis spinosa) in the treatment of ureteral stent-related symptoms — randomised controlled trial (combination product). Urologia. https://pubmed.ncbi.nlm.nih.gov/42244389/
  28. Minciullo PL, et al. (2017). Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 4: Solidago virgaurea-Vitis vinifera — review of adverse reactions. Contact Dermatitis, 77(2):67–87. https://pubmed.ncbi.nlm.nih.gov/28543097/
  29. North Carolina State University Extension. Solidago (goldenrod) — Extension Gardener Plant Toolbox — genus profile. https://plants.ces.ncsu.edu/plants/solidago/

From the Journal

View all articles →